2020
DOI: 10.4265/bio.25.159
|View full text |Cite
|
Sign up to set email alerts
|

Antibacterial Activity of Copper Nanoparticles-Chitosan Composite against <i>Vibrio parahaemolyticus</i>

Abstract: The Mekong Delta, Vietnam has traditionally been the major region of aqua produce accounting for over 52% of national aqua crop, and 65% of aqua export. In 2018, the aqua export value was over US$ 8.8 billion dollars, to which export of shrimp contributed 45%. However, pathogen infections directly influence the production and value-added contribution of shrimp in the region. The most common and serious infection is Early Mortality Syndrome (EMS) (or Acute Hepatopancreatic Necrosis Syndrome -AHPNS) caused by Vi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(1 citation statement)
references
References 22 publications
0
1
0
Order By: Relevance
“… 213 Similarly, chitosan-based copper nanoparticles exhibited efficient antibacterial activity against Vibrio parahaemolyticus . 214 Furthermore, biogenic metal and metal oxide nanoparticles exhibited antibacterial efficiency by various methods like damaging the plasma membrane (which leads to the bursting of the bacterial cells), the generation of excess ROS in the bacterial cell (which will lead to the increase in oxidative stress inside the cell), or the slow release of the drug (which will target the organelle), as described in Fig. 7 .…”
Section: Applicationsmentioning
confidence: 99%
“… 213 Similarly, chitosan-based copper nanoparticles exhibited efficient antibacterial activity against Vibrio parahaemolyticus . 214 Furthermore, biogenic metal and metal oxide nanoparticles exhibited antibacterial efficiency by various methods like damaging the plasma membrane (which leads to the bursting of the bacterial cells), the generation of excess ROS in the bacterial cell (which will lead to the increase in oxidative stress inside the cell), or the slow release of the drug (which will target the organelle), as described in Fig. 7 .…”
Section: Applicationsmentioning
confidence: 99%